Dermatology
RSSArticles
-
Esomeprazole in Patients with Upper GI Symptoms Taking NSAIDs, Including COX-2 Inhibitors
Esomeprazole 20 mg and 40 mg daily improve upper GI symptoms occurring during NSAID therapy including selective COX-2 inhibitors. -
Smoking Cessation: Bupropion or Nortriptyline?
Sustained release bupropion treatment is an efficacious aid to smoking cessation for patients at risk for and with chronic obstructive pulmonary disease. -
Lack of Differences Among Antidepressants
Only minimal differences in efficacy for treatment of major depressive disorders were found when SSRIs and 4 other 2nd generation antidepressants were compared to each other in randomized controlled trials, and almost all of the trials were sponsored by pharmaceutical companies. -
Daily Esomeprazole and Erosive Esophagitis
Although this study concluded that daily therapy with esomeprazole was superior to on-demand therapy, these results remain open to question. -
Should You Use Soybean Protein to Lower Your Patients’ Blood Pressure?
Soybean cookies reduced diastolic and systolic blood pressure by 3 to 4 mg Hg more than did carbohydrate cookies. -
Clinical Briefs in Primary Care supplement
-
Pharmacology Watch
Roche is Under Pressure Over Its Antiviral Drug Tamiflu; ACE Inhibitors or ARBs for Prediabetics?; Xigris is Approved for Severe Sepsis; ACE Inhibitors Inhibiting Aortic Valve Stenosis?; FDA Actions -
ECG Review: How Many PVCs?
-
Getting Practical with Monitoring in Type 2 Diabetes
A meta-analysis of the medical literature shows that self-monitoring of blood glucose by type 2 diabetics not on insulin does not improve control of the disease compared with regular monitoring of hemoglobin A1c (HbA1c). Patients spend considerable time and resources with daily monitoring of their blood sugars. Physicians increasingly rely on quarterly HbA1c levels as a marker of control. -
Clinical Briefs in Primary Care supplement